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KESAN ATRIAL NATRIURETIK PEPTIDA DAN KEHAMILAN KE ATAS 
PENGAWALATURAN PUSAT DAN PERIFERI FUNGSI-FUNGSI 
KARDIOVASKULAR 
 
ABSTRAK 
 
Kajian ini tertumpu pada dua topik yang berkaitan dengan pengembangan isipadu 
(VE); iaitu mengkaji kesan atrial natriuretik peptida (ANP) dan perubahan 
disebabkan kehamilan, ke atas pengawalaturan fungsi-fungsi kardiovaskular. ANP 
dirembes dari atria kardiak sebagai respon terhadap keadaan hipervolumia. 
Walaupun peranannya semasa VE sudah jelas, mekanisma pusat di sebalik kesan 
sistemik ANP kurang diselidik. Oleh itu, kajian ini bertujuan untuk mengkaji kesan 
sistemik dan pusat ANP, beserta penglibatan laluan vasopresin supra spina terhadap 
kesan selepas pemberian ANP secara intra venus. Hasil penemuan kami 
menunjukkan bahawa pemberian ANP secara sistemik pada dos rendah dan tinggi ke 
atas tikus jantan spesis Sprague-Dawley yang telah dibius dengan uretana 
menghasilkan kesan perencatan simpatetik renal yang signifikan, vasodilatasi dan 
bradikardia, di mana, kesan-kesan ini bergantung kepada efikasi laluan vasopresin 
supra spina. Pemberian ANP secara intra karotid melalui arteri karotid internal pula 
tidak menghasilkan sebarang kesan signifikan terhadap pembolehubah 
kardiovaskular yang direkod, mencadangkan bahawa kesan sistemik ANP tidak 
melibatkan tindakan ANP pada organ-organ sirkumventrikular. Pemberian ANP 
secara terus pada nukleus paraventrikular (PVN) menyebabkan kesan perencatan 
simpatetik renal yang berpanjangan, beserta kesan vasodilatasi dan bradikardia, 
menunjukkan tindakan ANP secara pusat. Pemerhatian ini, mencadangkan bahawa 
xviii 
 
tindakan spesifik di PVN kemungkinan terlibat dalam menghasilkan kesan sistemik 
oleh ANP. Sementara itu, bahagian kedua kajian, bertujuan mengkaji beberapa aspek 
kehamilan, suatu situasi di mana isipadu darah bertambah secara mendadak. 
Pengaruhan VE akut menggunakan infusi salina isotonik dalam tikus betina 
menyebabkan sedikit kenaikan pada purata tekanan arteri (MAP) dan kadar denyutan 
jantung (HR), dan menurunkan aktiviti saraf simpatetik renal (RSNA). 
Walaubagaimanapun, refleks takikardia dan perencatan simpatetik renal ini 
berkurang dalam tikus bunting, menunjukkan bahawa mekanisma refleks dalam 
mengekalkan keseimbangan cecair tubuh berubah pada fasa akhir kehamilan. 
Berikutan rangsangan dan penyahrangsangan baroreseptor arteri masing-masing 
menggunakan fenilefrina dan sodium nitroprusida, kehamilan menunjukkan indeks 
sensitiviti barorefleks yang sama, sama ada melalui pemberian agonis secara 
perlahan atau pantas. Kajian mencadangkan bahawa perubahan kronik dalam fungsi 
barorefleks semasa kehamilan tidak mengubah sensitiviti barorefleks arteri bagi HR 
dan RSNA terhadap perubahan MAP yang sementara. Dalam siri kajian berlainan, 
peranan sistem saraf simpatetik (SNS) dan nitrik oksida (NO) dalam pengawalan 
MAP basal semasa kehamilan diselidik, beserta respon vaskular terhadap beberapa 
jenis agen vasopressor dan agen vasodepressor ke atas tikus ternyahsaraf. Kajian 
mendapati peranan SNS terhadap MAP basal berkurang dalam tikus bunting, 
mencadangkan pengurangan tona simpatetik-kawalan-pusat ke atas sistem vaskular 
semasa fasa akhir kehamilan. Juga, kehamilan tidak mengubah peranan NO dalam 
mengekalkan tona vaskular basal, tetapi, pemerhatian kami menunjukkan bahawa 
interaksi antara SNS dan sistem NO semasa kehamilan telah berubah. Pada peringkat 
periferal, kehamilan menyebabkan  perubahan yang tidak seragam dari segi respon 
xix 
 
vaskular terhadap agen vasopressor dan vasodepressor yang diselidik pada seluruh 
sistem haiwan tanpa sebarang pengaruh kesan pusat dan refleks. 
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EFFECTS OF ATRIAL NATRIURETIC PEPTIDE AND PREGNANCY ON 
THE CENTRAL AND PERIPHERAL REGULATION OF THE 
CARDIOVASCULAR FUNCTIONS 
 
ABSTRACT 
 
The present study focuses on two topics that are related to volume expansion (VE); 
investigating the effect of atrial natriuretic peptide (ANP) and pregnancy-induced 
changes, in the regulation of the cardiovascular functions. ANP is released from the 
cardiac atria in response to hypervolemic state. Even though its role during VE is 
well established, the central mechanism underlying its systemic effect is less studied. 
Therefore, this study sets out to examine the systemic and central effect of ANP, as 
well as the involvement of supraspinal vasopressin pathways in mediating the effect 
produced by intravenous ANP. Our findings show that the systemic administration of 
low and high doses of ANP in urethane-anaesthetized male Sprague-Dawley rats 
produce a significant renal sympathoinhibition, vasodilation and bradycardia, and 
these effects are dependent on the efficacy of a well established supraspinal 
vasopressin pathway. Intracarotid administration of ANP via internal carotid artery 
does not produce any significant change in the recorded cardiovascular variables, 
suggesting that the systemic effect of ANP is independent of its action on the 
circumventricular organs. Direct administration of ANP into the paraventricular 
nucleus (PVN) causes a long lasting renal sympathoinhibition as well as vasodilation 
and bradycardia, demonstrating the central action of ANP. This observation, suggests 
that specific actions in the PVN might possibly mediate the expression of systemic 
effect by ANP. Meanwhile, the second part of the study, aims to investigate several 
xxi 
 
aspects of pregnancy; a state where the blood volume is greatly expanded. Induction 
of acute VE using isotonic saline infusion in female rats raises slightly the mean 
arterial pressure (MAP) and heart rate (HR), and reduces the renal sympathetic nerve 
activity (RSNA). However, these reflex tachycardia and renal sympathoinhibition are 
attenuated in pregnant rats, indicating that the reflex mechanisms in maintaining 
fluid balance are altered during late-term pregnancy. Following activation and 
deactivation of arterial baroreceptors using phenylephrine and sodium nitroprusside, 
respectively, pregnancy exhibits similar baroreflex sensitivity index, both by slow 
and rapid administration of agonists. It is proposed that chronic resetting of arterial 
baroreceptors, which has been reported during pregnancy, does not alter the arterial 
baroreflex sensitivity of HR and RSNA following transient changes in MAP. In 
different series of experiments, the roles of sympathetic nervous system (SNS) and 
nitric oxide (NO) in maintaining basal MAP during pregnancy are examined, as well 
as the vascular responsiveness to several vasopressor and vasodepressor agents in 
pithed rat preparation. It has been demonstrated that the role of SNS on basal MAP is 
reduced in pregnant rats, suggesting diminished centrally-regulated sympathetic tone 
to the vasculature during late-term pregnancy. Also, pregnancy does not alter the role 
of NO in maintaining basal vascular tone, however, our observation shows that the 
interaction between the SNS and NO system in pregnancy is somehow altered. At the 
peripheral level, pregnancy causes non-uniform changes in the vascular 
responsiveness to selective vasopressor and vasodepressor agents in a whole animal 
system without the influence of central and reflex effects. 
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GENERAL 
INTRODUCTION 
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CHAPTER ONE 
 
GENERAL INTRODUCTION 
 
1.1 Nervous system 
The nervous system can be divided into the central nervous system and the peripheral 
nervous system. A brief description of these two components of the nervous system 
is discussed below. 
  
1.1.1 Central nervous system (CNS) 
The CNS is basically composed of the brain and the spinal cord. Anatomically, the 
brain can be subdivided into four divisions, which are cerebrum, diencephalon, 
cerebellum and brainstem. The latter division, namely brainstem, consists of the 
midbrain, pons and medulla oblongata (Yusof, 1999).  
 
The spinal cord lies within the bony vertebral column. As seen in transverse sections, 
the central butterfly shaped area, namely the grey matter, is composed of 
interneurones, the cell bodies and dendrites of efferent neurones, the entering fibres 
of afferent neurones, and glial cells. The grey appearance of this core is due to the 
nerve fibres that lack myelin. On the other hand, groups of myelinated axons of 
interneurones make up an area called the white matter surrounding the grey matter of 
the spinal cord. These groups of axons run longitudinally through the spinal cord, 
either ascending, to relay information between different levels of the brain and the 
spinal cord, or descending, to transmit signals from the brain to the spinal cord. The 
groups of afferent fibres enter the spinal cord via the dorsal roots; meanwhile, axons 
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of efferent fibres leave the spinal cord via the ventral roots. Both dorsal and ventral 
roots from the same level merge to form spinal nerves, one on each side of the spinal 
cord (Yusof, 1999).  
 
1.1.2 Peripheral nervous system (PNS) 
Originating from the central parts, the PNS is made up of nerve fibres which extend 
from the brain or the spinal cord to the body’s muscles, glands and sense organs. 
This system is responsible for transmitting signals between the CNS and the effectors 
in all other parts of the body. Anatomically, the PNS consists of 43 pairs of nerves: 
12 pairs of cranial nerves and 31 pairs of spinal nerves. All 31 pairs of spinal nerves 
are then structured into four levels, namely cervical, thoracic, lumbar and sacral. A 
single nerve contains nerve fibres that are either the axons of afferent neurones or 
efferent neurones, or both. Based on the types of effectors being innervated, the 
efferent division can be subdivided into a somatic nervous system and autonomic 
nervous system (ANS). The neurones of the somatic division control voluntary 
movements, therefore innervate skeletal muscles. On the other hand, the autonomic 
neurones, which control involuntary responses, innervate all tissues other than 
skeletal muscles such as smooth and cardiac muscles, glands and neurones in the 
gastrointestinal tract (Yusof, 1999). 
 
The importance of the ANS in regulating body functions has been appreciated for 
many years. It is composed of two major divisions, which are sympathetic and 
parasympathetic components. Many organs are innervated by both divisions, 
whereby normally each controls antagonistic function to the other. For instance, in 
the heart, excitation of the sympathetic fibres causes tachycardia, whereas, 
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stimulation of the parasympathetic fibres produces bradycardic effect. At each side 
of the spinal cord, a two-neuron chain exists in a series between the CNS and the 
effector organs. The first-order neurones, called sympathetic preganglionic neurones 
(SPNs), pass between the CNS and ganglia, whereas the second-order neurones, 
namely sympathetic postganglionic neurones, connect the ganglia with the effector 
organs (Loewy, 1990a; Yusof, 1999; Guyenet, 2006). The sympathetic 
postganglionic neurones have direct influence on the target organs and their activity 
is controlled by the SPNs. 
 
With regard to sympathetic innervations, the motor outflow arises predominantly 
from the intermediolateral (IML) cell column of the thoracic and upper lumbar spinal 
cord. This outflow originates from the SPNs that are segmentally organized in the 
spinal cord (Loewy, 1990a). This was evident by neuroanatomical retrograde tracing 
methods using fluorescent labels or horseradish peroxidase, whereby the target 
organ-specified preganglionic neurones are located in specific spinal cord segments 
(Strack et al., 1988; Pyner and Coote, 1994). The innervations of two important 
organs that will be discussed in this present study, mainly the heart and kidney, 
originate from the upper and lower thoracic innervations, respectively. More specific, 
sympathetic innervations to the heart originate from T1-T4, whereas sympathetic 
innervations to the systemic arterioles, including renal arteries, originate 
predominantly in the thoraco-lumbar cord at T5-L2 level (Kawabe et al., 2009; Fig. 
1.1). This well organized structure of the spinal cord has made the CNS capable of 
generating highly differentiated patterns of sympathetic outflow to different target 
organs in response to various stimuli (Appel and Elde, 1988; Deering and Coote, 
2000; Sved et al., 2001). Differentiated patterns of regional sympathetic outflow are 
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probably expressed through activation of specific subgroups of neurones in the 
medulla committed to specific groups of SPNs which innervate appropriate target 
organs.       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1. Schematic illustration of the sympathetic nervous system (Adapted from 
Loewy, 1990a) 
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1.2 Central and peripheral regulation of cardiovascular system 
Vascular tissues, except for the capillaries and venules, receive sympathetic 
innervations of the ANS. These sympathetic fibres cause vasoconstriction, thereby 
also known as sympathetic vasoconstrictor fibres. The sympathetic nervous system 
maintains and greatly influences blood pressure (BP) by regulating the rate and force 
of contraction of the heart, and the calibre of the blood vessels. Therefore, any 
abnormality in sympathetic function will result in various types of cardiovascular 
diseases, such as hypertension, neurogenic cardiac arrhythmias and ischemic stroke 
(Yusof, 1999). 
 
1.2.1 Arterial pressure (AP) 
AP is a function of cardiac output and total peripheral resistance, two variables that 
are controlled by the ANS. Cardiac output, in turn, is dependent on three variables, 
which are end-diastolic volume, myocardial contractility and heart rate (HR). The 
heart receives both sympathetic and parasympathetic innervations of nervous system. 
Impulses in the sympathetic nerves increases the HR (chronotropic effect) and the 
force of cardiac contraction (ionotropic effect), whereas impulses in the 
parasympathetic or vagal nerves decrease the HR (Loewy, 1990a; Yusof, 1999).  
 
Total peripheral resistance is determined primarily by the contractile status of the 
microcirculation, in particular, the arterioles and small arteries (Lucca et al., 2000). 
In general, there are a number of factors that affect the calibre of the arterioles, such 
as local regulatory mechanism (osmolality, pH, oxygen and carbon dioxide tension), 
substances secreted by the endothelium (prostaglandins, thromboxanes, nitric oxide; 
NO, and endothelins), circulating hormones (kinins, vasoactive intestinal peptide, 
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atrial natriuretic peptide, vasopressin, noradrenaline, adrenaline and angiotensin II) 
and sympathetic innervations. In normal condition, the ANS and the endothelium 
works together to maintain the vascular tone, by exerting tonic balance between the 
release of vasodilators from the endothelium and vasoconstrictors from the 
sympathetic nerve terminals (Harris and Matthews, 2004). The sympathetic nervous 
system produces tonus activity on basal AP by releasing norepinephrine from 
sympathetic nerve endings (Zimmerman, 1962).   
 
1.2.2 Concept of a vasomotor centre 
The ideas on how the brain regulates the cardiovascular system starting from studies 
over the last 200 years, which have given shape to our current concept and better 
understanding of the cardiovascular mechanisms and their neural control. The basic 
concept began in 1870 when Dittmar transected a region in the ventral medulla of 
rabbits, and found that BP fell profoundly, while pressure responses elicited by 
stimulation of the peripheral nerves were attenuated (Yusof, 1999). In 1873, he 
concluded that the vasomotor centre lies in the ventrolateral reticular formation near 
the region of the superior olivary and facila nuclei (Yusof, 1999). These early 
findings provide a clue to the roles of ventral medulla in the maintenance of AP, thus 
initiating a better move towards implicating the importance of the medulla region in 
the regulation of vasomotor tone. 
 
1.2.2.1 Rostral ventrolateral medulla 
Several neuroanatomical retrograde tracing studies have identified that within the 
medulla, there are reticulospinal neurones projecting to the sympathetic columns in 
the spinal cord (Amendt et al., 1978; Dampney et al., 1982; Caverson et al., 1983; 
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Reis et al., 1984; Ross et al., 1984). This region, first identified in the rat by Reis and 
colleagues, became known as the rostral ventrolateral medulla (RVLM; Ross et al., 
1981) and was found to have direct monosynaptic connections with SPN (Zagon and 
Smith, 1993).  
 
The RVLM-spinal projecting sympathoexcitatory neurones play a crucial role in the 
tonic and phasic regulation of the sympathetic vasomotor activity and AP. This idea 
was provided by an extracellular recording study, whereby these neurones were 
found to be tonically active with the firing rates of 5-40 spikes/s (see review Coote, 
2006). In addition, the RVLM has been shown to provide major tonic excitatory 
drive to the sympathetic neurones that maintain AP (Dampney et al., 2003). 
Alteration in the activity of the RVLM-spinally projecting neurones seems to have 
profound effects on the sympathetic vasomotor tone (Dampney et al., 2003). 
Electrical or chemical stimulation of the RVLM neurones markedly increases 
sympathetic vasomotor activity, AP, and monosynaptically excited SPN (Dampney 
et al., 1982; Caverson et al., 1983; Morrison et al., 1988; Deuchars et al., 1995). This 
synaptic regulation of the RVLM sympathoexcitatory neurones is mediated by 
several neurotransmitters, such as glutamate and gamma-aminobutyric acid (GABA) 
(Stauss, 2002; Mayorov and Head, 2003; Horiuchi et al., 2004). 
 
However, by virtue of development and application of a wide range of new 
experimental techniques, many traditionally held beliefs about the concept of a 
vasomotor centre have changed. Studies over the last 30 years or so have shown that 
the RVLM neurones are not alone in directly controlling the sympathetic vasomotor 
outflow. The tonic activity exerted by the RVLM neurones is thought to result from 
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sympathoexcitatory and sympathoinhibitory input from other brain regions to the 
RVLM (Ito and Sved, 1997; Schreihofer and Guyenet, 2002; Dampney et al., 2003; 
Yusof, 2007). In fact, the use of anaesthetized or decerebrate animals in many studies 
seems to depress or even abolish the contribution of supramedullary-spinal 
projections on the cardiovascular responses. Other groups of neurones, particularly in 
the hypothalamus, have also been shown to have direct projections to the SPNs, thus 
revealing that the supramedullary regions are capable of influencing sympathetic 
outflows to cardiovascular tissues independent of the RVLM (Coote, 2006).  
 
In 1989, a method of transneuronal retrograde labelling by means of pseudorabies 
viruses was introduced to identify CNS cell groups that project their axons directly to 
the IML of the spinal cord (Strack et al., 1989). This study, together with the results 
from various workers (Jansen et al., 1995a), revealed five specific cell groups that 
innervate the SPNs in the spinal cord, mainly confined to several discrete regions 
within the brainstem and the hypothalamus. Besides the RVLM, there were 4 other 
regions demonstrated to have direct innervations to the SPNs, which were rostral 
ventromedial medulla (RVMM), caudal raphe nuclei, A5 noradrenergic cell group in 
the pons and the paraventricular nucleus (PVN) in the hypothalamus (Fig. 1.2) , and 
most importantly, seem to have influence on cardiovascular regulation. These 
neurones, which project directly to SPNs in the spinal cord, are called 
presympathetic neurones. These important findings bring a big impact on the current 
concept of vasomotor control, whereby it is now believed that the sympathetic 
vasomotor activity partly depends on signals originating from the supramedullary 
regions. In this particular study, only one of the supramedullary regions will be 
explained in great detail, which is the PVN. 
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Figure 1.2. Brainstem and hypothalamic inputs to the intermediolateral column of 
the spinal cord. VII nerve, facial nerve; IO, inferior olive; NTS, nucleus tractus 
solitarius; PB, parabrachial nucleus; SpV, spinal trigeminal nucleus; VMH, 
ventromedial nucleus of hypothalamus (Adapted from Dampney, 1994). 
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1.2.2.2 Paraventricular nucleus 
The PVN of the hypothalamus is located adjacent to the third ventricle in the 
forebrain. It is one of the five brain regions that directly innervate the SPNs in the 
spinal cord, thus capable of regulating sympathetic nerve outflows. There are three 
classes of PVN neurones; PVN neurones that directly project to the RVLM, PVN 
neurones that directly project to the spinal cord, and PVN neurones that have 
collateral projections to both the RVLM and spinal cord (Strack et al., 1989; Shafton 
et al., 1998; Pyner and Coote, 1997, 2000). The PVN-spinal neurones are mainly 
sympathoexcitatory, wherein the excitatory effect on renal sympathetic neurones is 
mediated in part by release of vasopressin and in part by glutamate (Yang and Coote, 
2007). 
 
With the advent of more sophisticated neuroanatomic tracing and 
immunohistochemical techniques, the functional cyto- and chemo-architecture of 
PVN have been explored, particularly in rats. Results from previous studies have 
driven to the subclassification of PVN neurones into two groups namely 
magnocellular and parvocellular neurones (Haselton et al., 1994; Shafton et al., 
1998). Large neurones of the magnocellular subdivision of PVN play important roles 
in neuroendocrine functions, where they synthesize arginine vasopressin and 
oxytocin. On the other hand, the parvocellular neurones, which contain smaller cells, 
are involved in the regulation of autonomic functions by virtue of their projections to 
autonomic nuclei of the brain stem and spinal cord (Haselton et al., 1994; Shafton et 
al., 1998). 
 
11 
 
PVN has been implicated in various body functions, including regulation of food 
intake, responses to stress, modulating metabolic rate, thermoregulation, and 
regulation of the cardiovascular function (Schlenker, 2005). With regard to 
cardiovascular regulation, PVN influences the sympathetic and parasympathetic 
nervous systems as well as neuroendocrine functions (Kenney et al., 2003a, b; 
Eduardo, 2005; Schlenker, 2005). Apart from its role in normal condition, there is 
evidence implicating PVN in cardiovascular diseases. For example, increased 
activity in PVN is associated with the sympathoexcitation observed in congestive 
heart failure, and ablation of PVN seems to attenuate the progression of increased BP 
in spontaneously hypertensive rats (Akine et al., 2003). 
 
Although PVN plays an important role in various body functions, the major focus of 
this study is on volume regulation. To date, the importance of PVN in volume 
regulation has been the subject of numerous articles and reviews (Lovick and Coote 
1988a, b; Lovick et al., 1993; Haselton et al., 1994; Deng and Kaufman, 1995; 
Badoer, 1997; Coote, 2006). This parallels with its projections with other autonomic 
nuclei that are also involved in central processing of volume signals, including 
dorsomedial nucleus of the hypothalamus (DMH), nucleus tractus solitaries (NTS), 
subfornical organ (SFO) and C1/A1 groups of catecholaminergic neurones of the 
ventrolateral medulla. The sympathetic nerve discharge bursting pattern of the PVN 
neurones is mediated by different chemically-coded pathways to the spinal cord 
(Yang et al., 2002; Kenney et al., 2003b).  
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1.3 Role of neurotransmitters and neuromodulators in central cardiovascular 
regulation 
The localization of various neuropeptides in the areas of brain that are known to play 
pivotal role in cardiovascular regulation has been achieved by the availability of 
newly advanced and sophisticated immunocytochemical and biochemical techniques. 
In mammalian CNS, glutamate appears to be the major fast excitatory 
neurotransmitter; meanwhile, GABA is known to be the principal neurotransmitter 
mediating fast inhibitory synaptic currents input (Gordon and Sved, 2002). Other 
examples of neurotransmitters or neuromodulators that are present in the brain are 
dynorphin, enkephalin, oxytocin, nitric oxide, 5-hydroxytryptamine, angiotensin II, 
vasopressin, endothelins, catecholamines, acetylcholine and glycine (Kenney et al., 
2003b; Li et al., 2003; Yang and Coote, 2003; Ng et al., 2004). 
 
The spinal cord also contains various types of neurotransmitters or neuromodulators 
that play important roles in the regulation of neuronal functions. The SPNs change 
their activity pattern, firing rate or membrane potential in response to a variety of 
neurotransmitters, including amino acids, monoamines and neuropeptides (Cammack 
and Logan, 1996; Deuchars et al., 1997). With regard to the PVN-spinal neurones, 
studies have shown that these neurones express either arginine vasopressin (25-40%) 
or oxytocin (20-30%) and, to a lesser extent, enkephalin or dopamine, which are now 
convincing to act as neurotransmitters in PVN-spinal sympathetic pathways (Coote, 
2006). These important findings were achieved by means of intrathecal application 
of selective receptor antagonists for each of the neurotransmitter employed (Yang et 
al., 2002). By virtue of its great influence on the effect of PVN–spinal neurones on 
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renal sympathetic activity (Yang and Coote, 2007), vasopressin has been chosen as 
the topic of discussion in our present study. 
 
1.3.1 Vasopressin and cardiovascular regulation 
Arginine vasopressin (AVP), a peptide hormone, is synthesized in magnocellular 
neurones of the supraoptic and the PVN of the hypothalamus. These neurones send 
their axons into the posterior lobe of the pituitary gland, from which AVP is released 
into nearby capillaries and distributed throughout the body. The peripheral actions of 
AVP are mediated by two subtypes of membrane-bound receptors. The V1a receptor 
mediates the vasoconstrictor actions of AVP via phosphatidyl inositol biphosphate 
hydrolysis and a rise in cytosolic Ca
2+
. Meanwhile, the V2 receptor mediates the 
antidiuretic effect of AVP on renal collecting ducts via adenylate cyclase (Berecek, 
1992; Brunton et al., 2008). 
 
The importance of AVP in cardiovascular regulation has been demonstrated in a 
number of studies (Porter and Brody, 1986; Berecek, 1992; Malpas and Coote, 1994; 
Yang et al., 2002; Yang and Coote, 2006; 2007; Brunton et al., 2008). There are 
evidences which indicate that AVP innervations of the spinal sympathetic neurones 
most probably arise from the PVN (Porter and Brody, 1986; Coote, 2004). From 
PVN, these AVP-containing neurones terminate in the dorsal horn and IML. 
Following PVN stimulation, the level of spinal AVP in the spinal fluid is increased 
(Malpas and Coote, 1994). Moreover, application of AVP to the spinal cord results in 
an increase in the firing rate of SPNs, an increase in BP and vasoconstriction in the 
renal vascular beds (Malpas and Coote, 1994). Selective blockade of spinal AVP 
receptors antagonizes excitatory effects on the RSNA following PVN stimulation 
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(Yang et al., 2002). Collectively, these evidences demonstrate the roles of AVP in 
mediating the descending pathways from the PVN to the IML of the spinal cord. 
Therefore, investigation at the spinal level, by some means, probably is a good 
approach for completing neural pathways subserving any cardiovascular mechanism 
being studied.     
 
1.4 Central and peripheral regulation of reflex cardiovascular system 
The preceding paragraphs are about the nervous control of cardiovascular system. 
Another important issue that also receives detailed attention will be on how these 
body systems are constantly maintained, for both short- and long-term period. The 
reflex arc, which forms a complete model for cardiovascular regulation, consists of 
sensory afferents, an efferent component and a central component that links the 
afferent input with the efferent output. In brief, the regulation of reflex 
cardiovascular system involves activation of several groups of afferent receptors, and 
their afferent input to the CNS modifies the discharge of the autonomic outflows to 
produce appropriate physiological responses. The variables that are being regulated 
include ABP, cardiac output, circulating blood volume, and arterial blood gas 
tensions (Spyer, 1990).  
 
Two types of receptors responsible for the reflex control of circulation are 
chemoreceptors and mechanoreceptors. The arterial chemoreceptors, located within 
the carotid bodies and aortic arch, have a chemosensitive function, in which they 
monitor the blood gas composition of the arterial blood. Meanwhile, the second 
group of receptors, known as machanoreceptors, can be further subdivided into two 
categories, namely arterial baroreceptors and cardiac receptors. Arterial 
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baroreceptors play essential role in monitoring BP whereas cardiac receptors have a 
great influence on body volume (Spyer, 1990). All these afferent signals are known 
to terminate in the nucleus tractus solitarius (NTS), an area that is important in 
cardiovascular regulation. Further details concerning both arterial baroreceptor reflex 
and cardiac receptor reflex, will be discussed at length later. 
 
1.4.1 Nucleus tractus solitarius (NTS) 
The NTS, an ovoid shaped nucleus, has been generally accepted as the major visceral 
sensory relay cell group in the brain. It receives signals from peripheral baroreceptor, 
chemoreceptor and cardiopulmonary afferents (Stauss, 2002; Kawabe et al., 2009). 
Anatomically, NTS is composed of several subnuclei, which can be classified on the 
basis of their position relative to the solitary tract. The incoming primary visceral 
afferent fibres that project to the NTS are organized in two ways, one for reflex 
adjustments of the end organ and the others for integrative functions involving more 
complex changes that affect multiple systems. The first involves an organ-specific 
projection pattern to individual NTS subnuclei, whereas the second relates to 
overlapping afferents projecting to a common NTS region, which is the commissural 
NTS. The reflex pathways seem to be more straightforward since it involves 
relatively simple neuronal circuits, probably only to specific lower brain stem nuclei. 
On the other hand, various inputs sent to the commissural NTS will be transmitted to 
and integrated by a variety of brain stem and forebrain nuclei, thus, commanding 
specific autonomic motor and neuroendocrine responses (Loewy, 1990b). Having 
direct projections to other parts of the brain that are known to be involved in 
cardiovascular control makes NTS a key nucleus for cardiovascular regulation. These 
include medullary and supramedullary regions such as caudal ventrolateral medulla 
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(CVLM), RVLM and hypothalamic PVN. Integration of these brain areas is 
important to elicit such reflex responses due to particular stimulus that will affect the 
body functions.             
 
1.4.2 Arterial baroreceptor reflex 
A growing body of evidence has shown that arterial baroreceptor input has a 
dominant influence on normal nervous control of BP. In fact, the organization and 
control of the baroreceptor reflex is a particular reflex mechanism for which the most 
detailed information is available in the literature (Shafton et al., 1999). This reflex 
seems to be important for stabilization of AP in the face of disturbances of 
circulatory homeostasis (Stauss, 2002). Mechanoreceptors that are located in the 
main systemic arteries, or to be more specific, in the aortic arch and carotid sinuses, 
are known as arterial baroreceptors. These high-pressure receptors are responsible for 
transmitting BP signals to the CNS via the aortic nerve, a branch of the vagus, for 
those with endings in the aortic arch. Meanwhile, for the receptors in the carotid 
sinus, the information is relayed through the sinus nerve, a branch of the 
glossopharyngeal nerve (Spyer, 1990). These arterial baroreceptor afferents have 
direct projections to three NTS areas: the dorsolateral NTS, the medial NTS and the 
commissural nucleus.     
 
A combination of a variety of experimental approaches, including the 
electrophysiological, pharmacological, neuroanatomical tracing and 
immunohistochemical studies, has resulted in a model of essential pathways 
subserving the baroreceptor reflex (Fig. 1.3). In brief, the arterial baroreceptors are 
activated or stimulated by the increased vascular stretch that accompanies a rise in 
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AP. Once NTS receives signals from the arterial baroreceptor afferents, the signals 
are transmitted to the CVLM via its excitatory neuronal projections, mainly 
involving glutamate neurotransmitters. Since CVLM is rich with GABAergic 
neurones some of which project directly to the RVLM, therefore, excitation of these 
neurones will inhibits the spinal-RVLM sympathoexcitatory neurones. Eventually, 
inhibition of the excitatory input to the SPNs in the spinal cord results in an 
inhibition of the sympathetic nerve activities to the organs and vascular beds 
involved in cardiovascular control (Urbanski and Sapru, 1988; Aicher et al., 1995; 
Shafton et al., 1999; Schreihofer and Guyenet, 2002; Moreira et al., 2005; Yusof, 
2007; Kawabe et al., 2009). In short, increased frequency of baroreceptor discharge 
will leads to reflex adjustments that will buffer the rise in AP, including an increase 
in vagal cardioinhibitory neurone discharges and a decrease in sympathetic 
preganglionic and postganglionic neurone discharges to the heart and peripheral 
blood vessels. Consequently, baroreceptor activation results in bradycardia, 
decreased cardiac contractility, and decreased peripheral vascular resistance. The fall 
in cardiac output and vascular resistance will then contributes to a decrease in AP. 
Conversely, a decrease in AP will results in appropriate changes in autonomic 
activity to increase AP back to the normal level.    
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Figure 1.3. Pathways within the lower brain stem and spinal cord that subserve the 
baroreceptor reflex control of the sympathetic outflow to the heart and blood vessels. 
The open triangle indicates excitatory synaptic inputs and the filled triangles, 
inhibitory synaptic inputs. CVLM, caudal ventrolateral medulla: IML, 
intermediolateral cell column in the spinal cord; NTS, nucleus tractus solitarius 
(Modified from Dampney et al., 2001) 
 
 
On reviewing the literature, there are two parameters that are often used to estimate 
the baroreflex function, namely the operating point of the reflex at which the reflex 
responds most effectively to changes in AP, and the sensitivity of the reflex or the 
magnitude of the reflex response per unit of ABP deviation from the operating point. 
In addition to these two parameters, recently, a baroreflex effectiveness index has 
been used as it provides information on how active the baroreflex is in BP, HR or 
RSNA regulation (Stauss, 2002). 
 
baroreceptors 
heart and 
blood vessels 
CVLM 
RVLM 
NTS 
IML 
19 
 
In several physiological or pathological conditions, resetting of arterial baroreceptors 
can occur, especially when there is a prolonged and sustained exposure to 
hypotensive or hypertensive states. This resetting, or sometimes known as adaptation 
of arterial baroreceptors, involves a shift in the operating set point of the receptor to 
levels that are closer to the new prevailing pressure. This resetting may or may not 
change the sensitivity of the arterial baroreflex responses. Examples of situations 
where chronic resetting of arterial baroreflex functions come into play are during 
pregnancy and hypertension (Brooks et al., 2002). 
 
1.4.3 Cardiac receptor reflex 
It has been well accepted that an optimum blood volume is vital for normal 
performance of all types of body functions; therefore, it is tightly regulated via 
detection of several plasma volume-related signals. The circulating levels of 
angiotensin, aldosterone and osmolality are examples of signals for long-term 
regulation of blood volume. Apart from that, the most important signals that directly 
reflect changes in vascular volume are the cardiac receptors (Badoer et al., 1998; 
Colombari et al., 2000; Potts et al., 2000; Coote, 2004). They have been reported to 
be sensitive enough to give a precise and rapid indication of the fullness of the 
thoracic circulation (Coote, 2004). These receptors are found to be localized in either 
the great veins close to their entry to the heart or within the walls of the atria, the 
atrial apendange, or the walls of the ventricles (Spyer, 1990). Of all the cardiac 
receptors, atrial receptors are the one that becomes active with each heartbeat and 
minimal information from epicardial and ventricular responses reach the CNS 
(Korner, 1971). These atrial receptors are also known as low-pressure receptors. 
They provide information on the circulating blood volume to the brain based on the 
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magnitude of the venous return and force of atrial contraction via the vagus nerve 
(Spyer, 1990; Coote, 2004). 
 
The important components of cardiac or volume reflex include the afferent limb 
(including receptors and afferent fibers), the central neural processing of afferent 
input and the efferent limb (RSNA and the release and /or action of humoral factors) 
(Patel, 1997). Like arterial baroreceptor afferents, cardiac afferents have been shown 
to terminate in the NTS. From NTS, it seems to connect to other autonomic nuclei 
which play important roles in blood volume regulation, thereby generating 
appropriate actions to restore normal blood volume. The most popular examples of 
situations where these mechanisms are clearly brought into play are haemorrhage and 
volume expansion (VE). However, in the present study, only reflex regulation of VE 
will be discussed in great detail. 
 
1.4.3.1 Volume expansion 
Blood volume is maintained homeostatically within its physiological level by the 
intrinsic, neural and humoral regulatory mechanisms. Of these regulatory 
mechanisms, neural regulation is characterised by its promptness in effect. The best 
known neural regulation of volume loading, namely Bainbridge reflex, refers to a 
tachycardic response to a rapid rise in blood volume (Kappagoda et al., 1975; 
Kaufman et al., 1981; Morooka et al., 2002; Coote, 2004). Simultaneously, a reflex 
inhibition of RSNA has been reported to compensate the increased in central blood 
volume (Potts et al., 2000; Coote, 2004, 2006), by altering the vascular resistance 
(Fiol et al., 1998) and affect both water and sodium excretion (Kaufman and Deng, 
1993). In addition, several studies have demonstrated that an acute increase in blood 
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volume induces responses such as renal vasodilation (Lovick et al., 1993; Colombari 
and Cravo, 1999; Pedrino et al., 2005), reductions in AVP, renin and aldosterone 
(Badoer et al., 1998), release of atrial natriuretic peptide and oxytocin (Godino et al., 
2005), natriuresis and diuresis (Badoer et al., 1998). Collectively, these responses 
help to restore blood volume to a normal level. 
 
During volume loading, volume receptors will respond to atrial and ventricular 
filling and eventually transmit the signals to the first synapse in NTS via the vagus 
nerve. From the NTS, the signal pass first to the CVLM and then to the RVLM, 
where the integrated afferent signals would be transmitted to the SPNs to produce 
appropriate responses. Besides medullary regions, the involvement of 
supramedullary regions such as PVN and other autonomic nuclei in the volume 
reflex regulation has been shown previously (Potts et al., 2000). This is due to the 
fact that both NTS and RVLM neurones do project to other parts of the brain regions. 
Studies using the expression of immediate-early gene c-fos, a marker of neuronal 
activation, have identified regions in the medulla and hypothalamus that are activated 
by acute VE, including, area postrema, the caudal, intermediate and rostral parts of 
the ventrolateral medulla, supraoptic nucleus, PVN, arcuate nucleus, suprachiasmatic 
nucleus and median preoptic nucleus (Potts et al., 2000). This and other 
neuroanatomical findings collectively indicate that the activation and coordination of 
the volume reflex responses resulted from the integration of CNS (Badoer et al., 
1997; Randolph et al., 1998; Shafton et al., 1999; Potts et al., 2000; Pyner et al., 
2002; Godino et al., 2005). Finally, the output produced from the central integration 
is reflected by the sympathetic nerve discharge innervating different target organs. 
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The present knowledge concerning the involvement of PVN in controlling cardiac 
reflex pathway is summarized in Figure 1.4. On reviewing the literature, evidence 
strongly favours the idea that inhibition of RSNA following atrial receptor 
stimulation is mediated by GABA interneurones in the PVN. These neurones 
regulate the RSNA by virtue of innervating the PVN-spinally projecting AVP 
neurones that synapse with renal SPNs (Yang et al., 2002; Yang and Coote, 2003, 
2004). Meanwhile, the reflex tachycardia responses seem to be attributed to 
activation of PVN-spinally projecting oxytocin neurones that innervate cardiac SPNs 
in the spinal cord. This latter response is mediated by the PVN interneurones-
containing glutamate. 
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Figure 1.4. Central nervous pathways controlling renal sympathetic neurone activity 
and the likely reflex pathway activated by atrial receptor stimulation which leads to 
inhibition of renal sympathetic activity and excitation of cardiac sympathetic activity. 
Abbreviations: AVP, arginine vasopressin; Glu, glutamate; NO, nitric oxide; NTS, 
nucleus tractus solitarius; OT, oxytocin; PVN, paraventricular nucleus; and RVLM, 
rostral ventrolateral medulla. Full arrow, excitatory pathway; dashed arrow, 
inhibitory pathway (Modified from Coote, 2004) 
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Examples of normal situations where chronic blood VE come into play are during 
exercise training and pregnancy (Randolph et al., 1998). Several pathological states 
such as congestive heart failure, cirrhosis, renal failure and nephritic syndrome, 
result from this volume overload (Shafton et al., 1999). 
 
Since VE is thought to be an important issue in clinical practice, the two main areas 
that will be investigated in the present study are also related to VE. These include the 
study of ANP, a hormone which is released by cardiac atria in response to VE. The 
systemic and central effects of ANP are explored, together with the central neurones 
participating in the systemic effect of ANP.  Meanwhile, the second part of the study 
will be focusing on pregnancy, a situation where blood volume is greatly expanded. 
This includes the study of reflex regulation of cardiovascular variables, such as 
MAP, HR and RSNA, in response to cardiac and arterial baroreceptor stimulation, as 
well as the study of peripheral system in this volume-expanded model. Taken 
together, the present study aims to investigate the effects of ANP and pregnancy, in 
relation to the regulation of the cardiovascular functions. 
 
 
 
